Ruben A. Mesa
15 Podcast Episodes
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Go online to PeerView.com/YJX860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
7 Aug 2023
•
1hr
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Go online to PeerView.com/YJX860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
7 Aug 2023
•
1hr
Similar People
Sorayah Bourenane
Adrian Hernandez
Suresh S. Ramalingam
Robert D. McBane
Kevin N. Sheth
Javed Butler
Yelena Y. Janjigian
Bruce R. Korf
Roy H. Decker
Kurt Schalper
Alok A. Khorana
Justin F. Gainor
Evan J. Lipson
Erika Hamilton
Benjamin Levy
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Go online to PeerView.com/YJX860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
7 Aug 2023
•
1hr
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics
Go online to PeerView.com/YJX860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
7 Aug 2023
•
1hr
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Go online to PeerView.com/ZZW860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
1hr 19mins
Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Go online to PeerView.com/ZZW860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
1hr 20mins
Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Go online to PeerView.com/ZZW860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
1hr 19mins
Ruben A. Mesa, MD, FACP - A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Ruben A. Mesa, MD, FACP - A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Go online to PeerView.com/CCY860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
10 Sep 2021
•
37mins
Ruben A. Mesa, MD, FACP - A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Ruben A. Mesa, MD, FACP - A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Go online to PeerView.com/CCY860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
10 Sep 2021
•
37mins
Ruben A. Mesa, MD, FACP - A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Ruben A. Mesa, MD, FACP - A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
Go online to PeerView.com/CCY860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
10 Sep 2021
•
37mins
